Skip to main content

EagleClaw Capital Managment, LLC

Position in ABBV — AbbVie Inc.

CIK 1607636 BOSTON, MA

Position in ABBV

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$18,061,209
+$2,351,037 QoQ
Shares Held
71,774
-0.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.48%
of 13F equity value
Holder Rank
#658
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. ABBV ranks #1 (39.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABBV
AbbVie Inc.
This page
71,774 $18,061,209

All Filings in ABBV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,061,209 71,774
2026-03-31 $15,710,172 72,234
2025-12-31 $16,335,664 71,494
2025-09-30 $16,699,590 72,124
2025-06-30 $13,719,545 73,912
2025-03-31 $15,489,185 73,927
2024-12-31 $12,407,902 69,825
2024-09-30 $13,404,349 67,877
2024-06-30 $11,837,452 69,015
2024-03-31 $12,672,339 69,590
2023-12-31 $10,846,350 69,990
2023-09-30 $10,440,162 70,040
2023-06-30 $9,293,675 68,980
2023-03-31 $10,875,408 68,240
2022-12-31 $11,070,285 68,500
2022-09-30 $9,202,108 68,565
2022-06-30 $10,496,054 68,530
2022-03-31 $11,259,350 69,455
2021-12-31 $9,636,824 71,173
2021-09-30 $7,580,348 70,273
2021-06-30 $7,631,247 67,749
2021-03-31 $6,990,903 64,599
2020-12-31 $6,356,566 59,324
2020-09-30 $4,812,982 54,949
2020-06-30 $5,105,261 51,999
2020-03-31 $3,970,718 52,116